Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

[Effects of recombinant soluble MICA protein on the biologic activities of NK cells].

Gong WJ, Wang HY, Fan MQ, Gong CX, Liu D, Ji MC.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Oct;25(10):903-6. Chinese.

PMID:
19811738
2.

[The roles of soluble MICA in immune escape of breast tumor].

Ye YB, Zhou ZF, Chen Q, Li JY, Chen X, Huang WW.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Sep;24(9):904-7. Chinese.

PMID:
18782524
3.

Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.

Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR.

J Immunol. 2008 Nov 15;181(10):6711-9.

4.

Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK cell-mediated cytotoxicity.

Fuertes MB, Girart MV, Molinero LL, Domaica CI, Rossi LE, Barrio MM, Mordoh J, Rabinovich GA, Zwirner NW.

J Immunol. 2008 Apr 1;180(7):4606-14.

5.
7.

[Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-gamma regulatory effect].

Zhang C, Tian Z, Hou G.

Zhonghua Zhong Liu Za Zhi. 2001 Sep;23(5):369-72. Chinese.

PMID:
11810763
8.

Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.

Arreygue-Garcia NA, Daneri-Navarro A, del Toro-Arreola A, Cid-Arregui A, Gonzalez-Ramella O, Jave-Suarez LF, Aguilar-Lemarroy A, Troyo-Sanroman R, Bravo-Cuellar A, Delgado-Rizo V, Garcia-Iglesias T, Hernandez-Flores G, Del Toro-Arreola S.

BMC Cancer. 2008 Jan 21;8:16. doi: 10.1186/1471-2407-8-16.

9.

[The negative regulatory effect of IFN-gamma on cognitive function of human natural killer cells].

Zhang C, Tian ZG, Zhang J, Feng JB, Zhang JH, Xu XQ.

Zhonghua Zhong Liu Za Zhi. 2004 Jun;26(6):324-7. Chinese.

PMID:
15312339
10.

Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.

Ghio M, Contini P, Negrini S, Boero S, Musso A, Poggi A.

Eur J Immunol. 2009 Dec;39(12):3459-68. doi: 10.1002/eji.200939728.

11.

Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1.

Poehlmann TG, Schaumann A, Busch S, Fitzgerald JS, Aguerre-Girr M, Le Bouteiller P, Schleussner E, Markert UR.

Am J Reprod Immunol. 2006 Nov-Dec;56(5-6):275-85.

PMID:
17076671
12.
13.

The inhibitory effects of synthetic short peptides, mimicking MICA and targeting at NKG2D receptors, on function of NK cells.

Zhang B, Wei H, Zheng X, Zhang J, Sun R, Tian Z.

Peptides. 2005 Mar;26(3):405-12.

PMID:
15652646
14.

Immobilized MHC class I chain-related protein A synergizes with IL-15 and soluble 4-1BB ligand to expand NK cells with high cytotoxicity ex vivo.

Gong W, Xiao W, Qian L, Gong C, Hu M, Pan X, Ji M.

Cell Mol Immunol. 2010 Nov;7(6):477-84. doi: 10.38/cmi.2010.41. Epub 2010 Sep 27.

15.

Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.

Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, Yamaguchi S, Hayashi N.

J Hepatol. 2005 Dec;43(6):1013-20. Epub 2005 Jun 29.

PMID:
16168521
16.

IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules.

Kubota A, Lian RH, Lohwasser S, Salcedo M, Takei F.

J Immunol. 1999 Dec 15;163(12):6488-93.

17.
18.

Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection.

Jinushi M, Takehara T, Kanto T, Tatsumi T, Groh V, Spies T, Miyagi T, Suzuki T, Sasaki Y, Hayashi N.

J Immunol. 2003 Feb 1;170(3):1249-56.

19.

MICA antigens stimulate T cell proliferation and cell-mediated cytotoxicity.

Zhang Y, Stastny P.

Hum Immunol. 2006 Mar;67(3):215-22. Epub 2006 Mar 31.

PMID:
16698445
20.

Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity.

Jinushi M, Hodi FS, Dranoff G.

Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9190-5. Epub 2006 Jun 5.

Supplemental Content

Support Center